Nonresponsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin of transforming growth factor β1 and CYP 1A1 gene expression in rat liver fat-storing cells

Toxicology and Applied Pharmacology

Volumn 152, Issue 1, 1998, Pages 251-260

  Riebniger, Dirk ^a   Schrenk, Dieter ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b University of Koblenz Landau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DRUG METABOLISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; ITO CELL; LIVER CELL CARCINOMA; LIVER CELL CULTURE; NONHUMAN; RAT; RECEPTOR GENE;

EID: 0031738246     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8460     Document Type: Article

References (65)

1. Akhurst, R. J., Fee, F., and Balmain, A. (1988). Localized production of TGF-beta mRNA in tumor promoter-stimulated mouse epidermis. Nature 331, 363-365.
2. Alitalo, R., Makela, T. P., Koskinen, P., Andersson, L. C., and Alitalo, K. (1988). Enhanced expression of transforming growth factor beta during megakaryoblastic differentiation of K562 leukemia cells. Blood 71, 899-906.
3. Andersen, M. E., Mills, J. J., Jirtle, R. L., and Greenlee, W. F. (1995). Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102, 223-237.
4. Bissell, D. M., Wang, S.-S., Jarnagin, W. R., and Roll, F. J. (1995). Cell-specific expression of transforming growth factor-β in rat liver. J. Clin. Invest. 96, 445-447.
5. 3H]retinol is transferred from hepatocytes to stellate cells in liver for storage. Exp. Cell Res. 150, 186-193.
6. Burke, D., and Mayer, R. (1974). Ethoxyresorufin direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2, 583-588.
7. Choi, E. J., Toscano, D. G., Ryan, J. A., Riedel, N., and Toscano, W. A. (1991). Dioxin induces transforming growth factor alpha in human keratinocytes. J. Biol. Chem. 266, 9591-9597.
8. Denison, M. S., Fisher, J. M., and Whitelock, J. P., Jr. (1989). Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. J. Biol. Chem. 264, 16478-16482.
9. Dragan, Y. P., Xu, X. H., Goldsworthy, T. L., Campbell, H. A., Maronpot, R. R., and Pitot, H. C. (1992). Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat. Carcinogenesis 13, 1389-1395.
10. Factor, V. M., Kao, C. Y., Santoni-Rugiu, E., Woitach, J. T., Jensen, M. R., and Thorgeirsson, S. S. (1997). Constitutive expression of mature transforming growth factor beta 1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res. 57, 2089-2095.
11. Feinberg, A. P., and Vogelstein, B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
12. Friedman, S. L. (1993). The cellular basis of hepatic fibrosis. N. Engl. J. Med. 328, 1828-1835.
13. Friedman, S. L., Roll, F. J., Boyles, J., and Bissell, D. M. (1985). Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA 82, 8681-8685.
14. Fort, P., Marty, L., Piechaezyl, M., Sabrouty, S. E., Dani, C., Jeanteur, P., and Blanchard, J. M. (1985). Various rat tissues express only one major mRNA species from the glycerinaldehyd-3-phosphate-dehydrogenase multigenic family. Nucleic Acid Res. 13, 1431-1443.
15. Gaido, K. W., and Maness, S. C. (1994). Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 127, 199-208.
16. Gant, T. W., Silverman, J. A., Bisgaard, H. C., Burt, R. K., Marino, P. A., and Thorgeirsson, S. S. (1991). Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinog. 4, 499-509.
17. Gressner, A. M. (1995). Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J. Hepatol. 22(Suppl. 2), 28-36.
18. 3H]-retinyl acetate and on the vitamin A status of the rat. J. Nutr. 115, 759-771.
19. 14C]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its effect on the vitamin A content in parenchymal and stellate cells of rat liver. J. Nutr. 119, 573-580.
20. Håkansson, H., Manzoor, E., Trossvik, C., Ahlborg, U. G., Chu, I., and Villeneuve, D. (1994). Effect on tissue vitamin A levels in the rat following subchronic exposure to four individual PCB congeners (IUPAC 77, 118, 126, and 153). Chemosphere 29, 2309-2313.
21. IARC (1997). Polychlorinated Dibenzo-para-Dioxins and Polychlorinated Dibenzofurans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 69, Lyon.
22. Jirtle, R. L., Hankins, G. R., Reisenbichler, H., and Boyer, I. J. (1994). Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 15, 1473-1478.
23. Kawada, N., Tran-Thi, T.-A., Klein, H., and Decker, K. (1993). The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Eur. J. Biochem. 213, 815-823.
24. Kitchin, K. T., Brown, J. L., and Woodrow Setzer, R. (1994). Dose-response relationship in multistage carcinogenesis: Promoters. Environ. Health Perspect. 102(Suppl. 1), 255-264.
25. Kim, S.-J., Glick, A., Sporn, M., and Roberts, A. B. (1989). Characterization of the promotor region of the human transforming growth factor β1 gene. J. Biol. Chem. 264, 402-408.
26. Kim, S.-J., Park, K., Koeller, D., Kim, K. Y., Wakefield, L. M., Sporn, M. B., and Roberts, A. B. (1992). Post-transcriptional regulation of the human transforming growth factor β1 gene. J. Biol. Chem. 2670, 13702-13707.
27. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., Hummel, R. A., and Humiston, C. G. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
28. Lai, Z.-W., Pinceau, T., and Esser, C. (1996). Identification of dioxin-responsive elements (DREs) in the 5′-regions of putative dioxin-inducible genes. Chem.-Biol. Interact. 100, 97-112.
29. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. Lucier, G. W., Tritscher, A., Goldsworthy, T., Foley, J., Clark, G., Goldstein, J., and Maronpot, R. (1991). Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increase in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 51, 1391-1397.
31. Maniatis, T., Fritsche, E., and Sambrook, J. (1989). Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
32. Massagué, J. (1990). The transforming growth factor β family. Annu. Rev. Cell. Biol. 6, 597-641.
33. Massagué, J., Attisano, L., and Wrana, J. L. (1994). The TGF β family and its composite receptors. Trends Cell Biol. 4, 172-178.
34. Matsumura, F., Enan, E., Dunlap, D. Y., Pinkerton, K. E., and Peake, J. (1997). Altered in vivo toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in c-src-deficient mice. Biochem. Pharmacol. 53, 1397-1404.
35. McDiarmid, S. V., Farmer, D. G., Kuniyoshi, J. S., Robert, M., Khadavi, A., Shaked, A., and Busuttil, R. W. (1994). The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation. Transplantation 58, 690-697.
36. Miyazono, K., Hellman, K., Wernsted, C., and Heldin, C.-H. (1988). Latent high molecular weight complex of transforming growth factor β1. J. Biol. Chem. 263, 6407-6415.
37. 1-450 (CYP1A1) gene. Int. J. Biochem. 21, 243-252.
38. Nillsson, C. B., Hanberg, A., Trossvik, C., and Hakansson, H. (1996). 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects retinol esterification in rat hepatic stellate cells and kidney. Environ. Toxicol. Pharmacol. 2, 17-23.
39. Oberhammer, F., Bursch, W., Parzefall, W., Breit, P., Erber, E., Stadler, M., and Schulte-Hermann, R. (1991). Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res. 51, 2478-2485.
40. Oesch, F., Arand, M., Coughtrie, M. W., Burchell, B., and Steinberg, P. (1992). The distribution of UDP-glucuronosyltransferase in rat liver parenchymal and nonparenchymal cells. Biochem. Pharmacol. 43, 731-737.
41. Okey, A. B., Riddick, D. S., and Harper, P. A. (1994). Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15, 226-232.
42. Okuno, M., Moriwaki, H., Imai, S., Muto, Y., Kawada, M., Suzuki, Y., and Kojima, S. (1997). Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology 26, 913-921.
43. Ooi, L. P. J., Crawford, D. H. G., Gotley, D. C., Clouston, A. D., Strong, R. W., Gobe, G. C., Halliday, J. W., Bridle, K. R., and Ramm, G. A. (1997). Evidence that myofibroblast like cells are the cellular source of capsular collagen in hepatocellular carcinoma. J. Hepatol. 26, 798-807.
44. Pack, R., Heck, R., Dienes, H. P., Oesch, F., and Steinberg, P. (1993). Isolation, biochemical characterization, long-term culture, and phenotype modulation of oval cells from carcinogen-fed rats. Exp. Cell. Res. 204, 198-209.
45. Pinzani, M. (1995). Novel insights into the biology and physiology of the Ito cell. Pharmacol. Ther. 66, 387-412.
46. Pitot, H. C., Goldsworthy, T., Campbell, H. A., and Poland, A. (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamin. Cancer Res. 40, 3616-3620.
47. Qian, S. W., Kondaiah, P., Roberts, A. B., and Sporn, M. B. (1990). cDNA cloning by PCR of rat transforming growth factor β1. Nucleic Acid Res. 18, 3059.
48. Roberts, A. B., and Sporn, M. B. (1988). Transforming growth factor β. Adv. Cancer Res. 51, 107-144.
49. Roberts, A. B., Thompson, N. L., Heine, U., Flanders, C., and Sporn, M. B. (1988). Transforming growth factor β: Possible roles in carcinogenesis. Br. J. Cancer 57, 594-600.
50. Schäfer, S., Zerbe, O., and Gressner, A. M. (1987). The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7, 680-687.
51. Schmitz, H. J., Hagenmaier, A., Hagenmaier, H., Bock, K. W., and Schrenk, D. (1995). Potency of mixtures of polychlorinated biphenyls as inducers of dioxin receptor-regulated CYP1A activity in rat hepatocytes and H4IIE cells. Toxicology 99, 47-54.
52. Schrenk, D., Buchmann, A., Dietz, K., Lipp, H. P., Brunner, H., Sirma, H., Münzel, P., Hagenmaier, H., Gebhardt, R., and Bock, K. W. (1994). Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins. Carcinogenesis 15, 509-515.
53. Sewall, C. H., Lucier, G. W., Tritscher, A. M., and Clark, G. C. (1993). TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenesis action of TCDD. Carcinogenesis 14, 1885-1893.
54. Steinberg, P., Lafranconi, W. M., Wolf, R., Waxman, D. J., Oesch, F., and Friedberg, T. (1987). Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in liver. Mol. Pharmacol. 32, 463-470.
55. Stinchcombe, S., Buchmann, A., Bock, K. W., and Schwarz, M. (1995). Inhibition of apoplosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumor promotion in rat liver. Carcinogenesis 16, 1271-1275.
56. Strain, A. J., Frazer, A., Hill, D. J., and Milner, R. D. (1987). Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem. Biophys. Res. Commun. 145, 436-442.
57. Sutter, T. R., Guzman, K., Dold, K. M., and Greenlee, W. F. (1991). Targets for dioxin: Genes for plasminogen activator inhibitor 2 and interleukin-1 beta. Science 254, 415-418.
58. Tamano, S., Merlino, G. T., and Ward, J. M. (1994). Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Carcinogenesis 15, 1791-1798.
59. Thorgeirsson, S. S., Santoni-Rugiu, E., Davis, C. D., and Snyderwine, E. G. (1997). Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/ c-myc double-transgenic mice. Arch. Toxicol. Suppl. 19, 359-366.
60. Thunberg, T., Ahlborg, U. G., Krantz, C., and Monier, M. (1980). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic storage of retinol in rats with different dietary supplies of vitamin A (retinol). Arch. Toxicol. 45, 273-285.
61. Vogel, C., and Abel, J. (1995). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. Arch. Toxicol. 69, 259-265.
62. Wake, K. (1980). Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int. Rev. Cytol. 66, 303-353.
63. Wollenberg, G. K., Semple, E., Quinn, B. A., and Hayes, M. A. (1987). Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-β. Cancer Res. 47, 6595-6599.
64. Wörner, W., and Schrenk, D. (1996). Influence of liver tumor promotors on apoptosis in rat hepatocytes induced by 2-acetylaminiofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res. 56, 1272-1278.
65. Zhang, J. X., Pegoli, W. J. R., and Clemens, M. G. (1994). Endothelin-1 induces direct constriction of hepatic sinusoids. Am. J. Physiol. 266, G624-G632.